European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-27

Advancement of hearing assessement methods and devices - immediate intervention

Objectif

Within the past 3-4 years, scientists and clinicians have demonstrated the feasibility, reliability, and effectiveness of early detection of infants with hearing loss through universal newborn hearing screening (UNHS) based onotoacoustic emissions (Oases). OAE technology has been entirely developed in the Equals as a result of previous EC projects (Biomedicine & Health). UNHS is becoming standard of care in the most advanced maternity clinics. Oases are produced byte outer hair cells. They contain contractile proteins, play a crucial role in peripheral coding under the control of higher neural centres and are essential to normal cochlear function. Absence or alterations of Oases is the method to assess even mild peripheral hearing losses. These technologies were entirely developed in Europe and are being applied by European manufacturers who still maintain the technical leadership in the field (with a share of almost 90% of the whole market).

Appel à propositions

Data not available

Régime de financement

THN - Thematic network contracts

Coordinateur

NATIONAL RESEARCH COUNCIL OF ITALY
Contribution de l’UE
Aucune donnée
Adresse
Piazza Leonardo Da Vinci 32
20133 MILANO
Italie

Voir sur la carte

Coût total
Aucune donnée

Participants (50)